ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Using Ensembles of Machine Learning Classifiers to Maximize the Accuracy and Stability of Molecular Biopsy Interpretation

    J. Reeve1, K. S. Madill-Thomsen2, P. F. Halloran and the INTERCOMEX Study Group3

    1University of Alberta, Edmonton, AB, Canada, 2Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton AB, AB, Canada, 3University of Alberta, Edmonton AB, AB, Canada

    *Purpose: The Molecular Microscope diagnostic system (MMDx), based on microarray gene expression, uses ensembles of machine learning classifiers rather than single genes, gene sets, or…
  • 2019 American Transplant Congress

    Using a Commercially Available Assay That Measures Cytomegalovirus-Specific CD4+ and CD8+ T-cell Immunity to Predict Clinically Significant Cytomegalovirus Events in Solid Organ Transplant Recipients

    R. Rogers1, K. Saharia2, A. Chandorkar2, Z. Weiss3, D. Farmakiotis1

    1Infectious Diseases, Brown University, Providence, RI, 2Infectious Diseases, University of Maryland, Baltimore, MD, 3Internal Medicine, Brown University, Providence, RI

    *Purpose: To assess the diagnostic performance and clinical utility of the Viracor CMV T-cell Immunity Panel (CMV-TCIP), which measures both CMV-specific Cd4+ and Cd8+ T-cell…
  • 2019 American Transplant Congress

    Capitalizing On Donor Density To Increase Organ Pool – An Analysis Of Urban And Rural Organ Donors

    S. Bakhtiyar, S. Ahmed, J. A. Goss, A. Rana

    Baylor College of Medicine, Houston, TX

    *Purpose: The primary factor limiting access to organ transplantation is the limited supply of deceased donor allografts. While there are multiple potential strategies to increase…
  • 2019 American Transplant Congress

    Preservation of Pancreatic Islets with Stem Cell Derived CD34+ Vascular Endothelial Progenitor Cells

    C. Ward1, L. Vo2, E. De Klerk2, G. Faleo2, Y. Kelly1, J. Bluestone2, M. Hebrok2, P. Stock1, Q. Tang1

    1Surgery, UCSF, San Francisco, CA, 2Diabetes Center, UCSF, San Francisco, CA

    *Purpose: Islet transplantation can cure Type 1 diabetes; however, multiple donors are needed due to extensive perioperative loss of islets when removed from their native…
  • 2019 American Transplant Congress

    Intra-abdominal Hypertension And Abdominal Compartment Syndrome: An Organ Procurement Organization’S Experience

    J. Stefek1, L. E. Markham1, M. Ott1, S. S. Johnson2, J. C. Olson3, H. Sangha4, D. G. Vasquez5, S. P. Whitt6, H. E. Wilkins1, P. A. Webster1, M. Iliakova7, M. Moncure7

    1Midwest Transplant Network, Westwood, KS, 2Via Christi St Francis, Wichita, KS, 3University of Kansas Medical Center, Kansas City, KS, 4Lake Regional Health System, Osage Beach, MO, 5Wesley Medical Center, Wichita, KS, 6University of Missouri Health Care, Columbia, MO, 7University of Missouri - Kansas City, Kansas City, MO

    *Purpose: Because of a shortage of available organs, an average of 22 people die each day waiting for a transplant. There has been significant research…
  • 2019 American Transplant Congress

    Intravenous Immunoglobulin Significantly Reduces Bioavailability of Concomitantly Administered Anti-C5 Monoclonal Antibodies

    S. C. Jordan1, K. Kucher2, M. Bagger2, H. Hockey3, K. Wagner4, N. Ammerman1, J. Choi1, A. Vo1

    1Comprehensive Transplant Center, Cedars-Sinai Medical Ctr, Los Angeles, CA, 2Novartis Institutes for BioMedical Research, Basel, Switzerland, 3Biometrics Matters Ltd, Hamilton, New Zealand, 4Novartis Institutes for BioMedical Research, Cambridge, MA

    *Purpose: Awareness of drug-drug interactions is critical in management of organ transplant recipients. However, there is little understanding of the possibility of biologic agents interfering…
  • 2019 American Transplant Congress

    Keeping Patients Lifetime Perspective in Focus: Modest Rates and Wide Variation in Preemptive Re-Listing for Kidney Transplantation in the US

    J. Schold, J. Augustine, A. Huml, J. O'Toole, J. Sedor, E. Poggio

    Cleveland Clinic, Cleveland, OH

    *Purpose: Success of transplantation is not limited to initial receipt of a donor organ. Many patients experience graft loss within their lifetime and the benefits…
  • 2019 American Transplant Congress

    Factors Associated with Cardiovascular Subclinical Target Organ Damage in Liver Transplant Recipients

    C. Kuepper1, N. Memaran1, B. Borchert1, A. von Wick1, E. Bauer1, E. Jäckel2, S. Ziegert2, B. M. Schmidt3, A. Melk1

    1Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany, 2Department of Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany, 3Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany

    *Purpose: Liver transplantation (LT) patients are prone to cardiovascular (CV) morbidity, since LT-related factors can add to the burden of classical risk factors. The aim…
  • 2019 American Transplant Congress

    Living Kidney Donors Who Lose Weight in Order to Be Able to Donate, Gain More Weight after Donation

    S. R. Punjala, L. Silas, R. Gokmen, N. Karydis

    Department of Nephrology, Renal Transplant and Urology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom

    *Purpose: Living donor kidney transplantation is widely accepted to be the treatment of choice for end-stage kidney disease, and great efforts are undertaken to expand…
  • 2019 American Transplant Congress

    Risk Factors for 1-5 Year Major Infection Events (MIE) after Kidney Transplant (KTx) Including First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity (CISTEM) Study

    V. Dharnidharka1, D. Axelrod2, Z. Zhang3, M. Schnitzler3, K. Lentine3, B. Kasiske4

    1Washington Univ, St. Louis, MO, 2Univ of Iowa, Iowa City, IA, 3Saint Louis Univ, St. Louis, MO, 4SRTR, Minneapolis, MN

    *Purpose: From our CISTEM study of linked national registries, we reported that older recipient age, female sex, diabetic kidney failure, non-standard-criteria organs, and mTORi-based IS…
  • « Previous Page
  • 1
  • …
  • 137
  • 138
  • 139
  • 140
  • 141
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences